Patent · US Active

Azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission

US10287247B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB · SE

Inventors

Fredrik Pettersson · Handen, SE
Clas Sonesson · Lindome, SE

Key dates

Filing date	Sep 27, 2018
Grant date	May 14, 2019
Priority date	—
Expiry date	Sep 27, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to certain novel compounds and to their utility in modulation of levels of monoamines, dopamine, norepinephrine and serotonin, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.